← All stocks

MBX Biosciences, Inc.

MBX No buying or selling
CIK 0001776111 #1706 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
127×

P. Kent Hawryluk holds 127 times base salary in stock. $79.87M of shares against $625.00K in salary for 2025.

Salary from the company's own proxy. The shares are what P. Kent Hawryluk last reported holding, valued at $65.77, the price Common Stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Heron Patrick J
Director
5,219,440
$343.28M
+14.6%
Hawryluk P. Kent
President & CEO
1,214,444
$79.87M
+38.1%
ORBIMED ADVISORS LLC entity
Director
747,887
$49.19M
+34.2%
GORDON CARL L
Director
747,887
$49.19M
+34.2%
Hoerter Steven L.
President and CEO
102,938
$6.77M
Smither John W
Chief Financial Officer
28,000
$1.84M
Pescovitz Ora H.
Director
24,329
$1.60M
+46.2%
Bartram Richard
Chief Financial Officer
15,000
$986.55K
Azoulay Salomon
Chief Medical Officer
14,399
$947.02K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 13 Sep 2024